Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed?
Recruiting
Observational Study
Hematuria
Acute Cystitis With Hematuria
Bladder Cancer
Urothelial Carcinoma
Renal Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 110
- Sex
- Female
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- Vastra Gotaland Region · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective multicenter observational study evaluates whether women ≥50 years with isolated acute hemorrhagic cystitis (AHC) and macroscopic hematuria require full malignancy workup. All participants undergo standard diagnostics (cystoscopy, CT urography, cytology), with 12-month follow-up for cancer detection. The aim is to identify low-risk patients where invasive investigations may be safe…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Women ≥50 years of age.
2. Macroscopic hematuria.
3. Presenting for evaluation within the SCP for macroscopic hematuria.
4. Ability to provide informed consent.
Exclusion Criteria:
1. Prior diagnosis of bladder cancer, renal cancer, or upper tract urothelial carcinoma (UTUC…
Contacts